Capital Flow Monitor · Sponsors · CIK 2104142
ABLi Therapeutics, Inc.
3350 RIVERWOOD PKWY SE, ATLANTA, GA, 30339 · 917-494-0831
Pharmaceuticals · Corporation· inc. DELAWARE true 2025
Fit score
—
Offering
$1.0M
Sold
$1.0M
% sold
100.0%
Investors
10
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-01-13 | D ·current | 506(b) | $1.0M | $1.0M | 100.0% | 10 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Milton H. Werner — Executive Officer / Director, Atlanta, GA
-
Garth Lees-Rolfe — Executive Officer, Atlanta, GA
1 other raise
- PANGIA BIOTECH, INC. $1.6M of $1.6M · 100.0%
- Anastasia Daifotis — Director, Atlanta, GA
-
Jeffrey Young — Director, Atlanta, GA
1 other raise
- OCP Payments CV, L.P. $32.0M of $32.0M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.